Your browser doesn't support javascript.
loading
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Apostolova, Petya; Kreutmair, Stefanie; Toffalori, Cristina; Punta, Marco; Unger, Susanne; Burk, Ann-Cathrin; Wehr, Claudia; Maas-Bauer, Kristina; Melchinger, Wolfgang; Haring, Eileen; Hoefflin, Rouven; Shoumariyeh, Khalid; Hupfer, Valerie; Lauer, Eliza Maria; Duquesne, Sandra; Lowinus, Theresa; Gonzalo Núñez, Nicolás; Alberti, Chiara; da Costa Pereira, Sara; Merten, Carla Helena; Power, Laura; Weiss, Matthias; Böke, Caroline; Pfeifer, Dietmar; Marks, Reinhard; Bertz, Hartmut; Wäsch, Ralph; Ihorst, Gabriele; Gentner, Bernhard; Duyster, Justus; Boerries, Melanie; Andrieux, Geoffroy; Finke, Juergen; Becher, Burkhard; Vago, Luca; Zeiser, Robert.
Affiliation
  • Apostolova P; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kreutmair S; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Toffalori C; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Punta M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Unger S; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, Division of Immunology, Transplantation and Infectious Disease, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Burk AC; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, Division of Immunology, Transplantation and Infectious Disease, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Wehr C; Center for OMICS Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Maas-Bauer K; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Melchinger W; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Haring E; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hoefflin R; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Shoumariyeh K; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Hupfer V; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lauer EM; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Duquesne S; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lowinus T; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gonzalo Núñez N; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Alberti C; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • da Costa Pereira S; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Merten CH; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Power L; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Weiss M; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Böke C; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Pfeifer D; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Marks R; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Bertz H; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Wäsch R; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Ihorst G; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gentner B; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Duyster J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Boerries M; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Andrieux G; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Finke J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Becher B; Clinical Trials Unit, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Vago L; Translational Stem Cell and Leukemia Unit, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Zeiser R; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Br J Haematol ; 203(2): 264-281, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37539479
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Health_technology_assessment / Prognostic_studies Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Health_technology_assessment / Prognostic_studies Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: Germany